Advanced Orthomolecular Research Inc
FDA import alert and refusal historyCalgary, CanadaFEI 3010118561
As of October 26, 2026, Advanced Orthomolecular Research Inc is not on any FDA import alert in SupplierRadar's records; FDA refused 10 of its shipment lines between February 27, 2018 and February 4, 2021, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Advanced Orthomolecular Research Inc
10 records, newest first. Each line links to the FDA page it came from.
2021
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 9R3-0010157-5Source
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 9R3-0010156-7Source
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-8590682-1Source
2020
- Import refusalSource
Refused, 6 lines in one entry: Vitamin e (tocopherol); Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Show 6 linesHide lines
- Refused, Vitamin e (tocopherol)UNAPPROVEDEntry AEK-7870081-9Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry AEK-7870081-9Source
2018
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 300-2545773-0Source
Refusal charges, in plain English
- UNAPPROVED10 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Advanced Orthomolecular Research Inc
- Is Advanced Orthomolecular Research Inc on an FDA import alert?
- No listing for Advanced Orthomolecular Research Inc appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Canada page.
- Has FDA refused shipments from Advanced Orthomolecular Research Inc?
- Yes. FDA refused 10 shipment lines from Advanced Orthomolecular Research Inc between February 27, 2018 and February 4, 2021. The most recent, on February 4, 2021, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Advanced Orthomolecular Research Inc's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 10 lines).
- What is Advanced Orthomolecular Research Inc's FEI number?
- Advanced Orthomolecular Research Inc's FDA Establishment Identifier (FEI) is 3010118561.
Buying from Advanced Orthomolecular Research Inc?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.